Skip to main content

Verastem, Inc. (VSTM) Stock Forecast

Data as of May 2, 2026

Healthcare · Current price $5.86 (+7.33%)

Consensus Target
$16.00
Upside
+215.7%
Analysts
4
Rating
Buy(2.00)

Price Target Range

Low $13.00Consensus $16.00High $19.00
▲ Current $5.86

Consensus Price Target Over Time

Analyst Rating Distribution

Last 3 Months

Consensus
Buy
Strong Buy0
Buy4
Hold0
Sell0
Strong Sell0

6-Month Trend

Latest Analyst Forecasts

Price targets issued by Wall Street analysts. Upside calculated against today's price.

DateAnalystFirmPrice TargetUpside
Mar 5, 2026Clara DongJefferies$19.00+224.2%
Oct 21, 2025Graig SuvannavejhMizuho Securities$14.00+138.9%
Oct 21, 2025Swayampakula RamakanthH.C. Wainwright$14.00+138.9%
Mar 24, 2025Michael SchmidtGuggenheim$14.00+138.9%
Jul 29, 2024Graig SuvannavejhMizuho Securities$7.00+19.5%
May 24, 2024Justin ZelinBTIG$13.00+121.8%
Apr 15, 2022Gregory RenzaRBC Capital$5.00-14.7%

VSTM vs Sector & Market

MetricVSTMHealthcare AvgLarge Cap Avg
Analyst Rating2.002.242.41
Analyst Count4818
Target Upside+215.7%+1150.0%+14.9%
P/E Ratio-2.176.8731.19

Revenue Estimates

PeriodLowAvgHigh#
2026-06-30$26M$27M$27M5
2026-09-30$28M$31M$36M2
2026-12-31$35M$38M$45M2
2027-12-31$182M$202M$233M6
2028-12-31$297M$302M$307M7
2029-12-31$402M$444M$514M3
2030-12-31$540M$597M$690M6

EPS Estimates

PeriodLowAvgHigh#
2026-06-30$-0.43$-0.41$-0.392
2026-09-30$-0.52$-0.43$-0.371
2026-12-31$-0.43$-0.35$-0.311
2027-12-31$-1.20$-1.00$-0.883
2028-12-31$-0.98$-0.45$-0.066
2029-12-31$0.17$0.19$0.234
2030-12-31$0.85$0.97$1.172

Frequently Asked Questions

What is the analyst consensus for VSTM?

The consensus among 4 analysts covering Verastem, Inc. (VSTM) is Buy with an average price target of $16.00.

What is the highest price target for VSTM?

The highest price target for VSTM is $19.00, set by Clara Dong at Jefferies on 2026-03-05.

What is the lowest price target for VSTM?

The lowest price target for VSTM is $5.00, set by Gregory Renza at RBC Capital on 2022-04-15.

How many analysts cover VSTM?

4 analysts have issued ratings for Verastem, Inc. in the past 12 months.

Is VSTM a buy or sell right now?

Based on 4 analyst ratings, VSTM has a consensus rating of Buy (2.00/5) with a +215.7% upside to the consensus target of $16.00.

What are the earnings estimates for VSTM?

Analysts estimate VSTM will report EPS of $-0.41 for the period ending 2026-06-30, with revenue estimated at $27M.

Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.